The global atherectomy devices market is expected to reach USD 894.69
million by 2025, based on a new report by Grand View Research, Inc. The demand
for atherectomy devices market is anticipated to boost over the forecast period
due to rapidly rising incidence of target diseases such as peripheral artery
disease.
New technologies and product approvals are
expected to boost the market for orbital and laser atherectomy devices over the
forecast period. For instance, in July 2016, Cardiovascular Systems Inc.
submitted an application for approval to Pharmaceuticals and Medical Devices
Agency (PMDA), Japan’s regulatory agency for pharmaceuticals and medical
devices. The company intends to launch Diamondback 360 Coronary OAS Micro Crown
in the region and is looking for potential distributors. This would be the
company’s first international market entry and the approval procedure is yet to
be completed.
Full research report on atherectomy devices market analysis:
http://www.grandviewresearch.com/industry-analysis/atherectomy-device-market
http://www.grandviewresearch.com/industry-analysis/atherectomy-device-market
Further Key Findings from the Study Suggest:
·
Directional atherectomy devices was the
largest segment in terms of revenue in the year 2016. This can be attributed to
their capability of collecting the shaved plaque in a collecting space, which
reduces the risk of barotrauma, dissection, and neointimal hyperplasia.
·
Laser atherectomy devices is expected to
the fastest growing segment over the next 8 years. Laser technique is perceived
as to have more precision in plaque removal and cause fewer complications. It
is also believed to result in lesser incidence of restenosis.
·
Geographically, North America held the
largest market share in 2015 and is expected to maintain its position during
the forecast period. A high prevalence of Peripheral Artery Diseases (PAD) in
this region is one of the key reasons for high demand of atherectomy. Almost
8.5 million people suffer from PAD in the U.S., resulting in an annual economic
burden of nearly USD 160 million.
·
Asia Pacific is anticipated to observe the
fastest growth over the coming years. Improving economic conditions leading to increasing
prevalence of lifestyle diseases, especially cardiovascular and peripheral, is
the key reason for this growth.
·
Some of the key industry contributors are
Boston Scientific Corporation, Cardiovascular Systems Inc., Medtronic
(Covidien), Spectranetics, VOLCANO CORPORATION, Avinger Inc., Bayer AG, Straub
Medical AG, ST. JUDE MEDICAL, BARD Peripheral Vascular, Cardinal Health
(Cordis), and Terumo IS.
View
more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the atherectomy devices market by type
and region:
Atherectomy Devices Type Outlook (Market
Revenue in USD Million, 2014 - 2025)
·
Directional atherectomy devices
·
Rotational atherectomy devices
·
Orbital atherectomy devices
·
Laser atherectomy devices
Atherectomy Devices Regional Outlook
(Market Revenue in USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
·
Middle East and Africa
o
South Africa
Access press release by Grand View
Research:
https://www.grandviewresearch.com/press-release/global-atherectomy-device-market
https://www.grandviewresearch.com/press-release/global-atherectomy-device-market
About Grand View Research
Grand View
Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
